Reveri.com is a digital health startup that offers personalized self-hypnosis sessions to help individuals manage stress, anxiety, and unwanted habits. The company's services are based on over 40 years of clinical research by Dr. David Spiegel, a leading psychiatrist at Stanford University and the company's Co-Founder and Chief Scientific Officer. Reveri's unique selling proposition lies in its evidence-based approach, with over 400 research papers validating the effectiveness of its hypnosis therapy.

Reveri's primary market is individuals seeking non-pharmacological interventions for stress, anxiety, and habit control. The company's business model is likely based on a subscription service, where members pay a recurring fee for access to personalized hypnosis sessions. This model provides a steady stream of revenue and allows the company to scale its services to a large number of users.

The company's value proposition is compelling. According to the company, 94% of its members reported an immediate reduction in stress and anxiety, and 88% reported increased control over their unwanted habits. These figures suggest that Reveri's services are not only effective but also have immediate benefits, which could make them attractive to individuals seeking immediate relief from their symptoms.

In conclusion, Reveri.com is a promising startup in the digital health space, offering evidence-based, personalized self-hypnosis sessions to help individuals manage stress, anxiety, and unwanted habits. The company's strong scientific foundation and compelling value proposition make it a strong contender in the growing market for digital mental health solutions.

Keywords: Digital Health, Self-Hypnosis, Stress Management, Anxiety Management, Habit Control, Personalized Therapy, Subscription Model, Evidence-Based, Mental Health Solutions, Non-Pharmacological Interventions.